LONDON, Dec 23 (Reuters) - AstraZeneca Plc (AZN.L: Quote, Profile, Research) has agreed to buy privately owned biotech firm KuDOS Pharmaceuticals for $210 million in the latest move to bolster its new product pipeline, Europe’s third-largest drug maker said on Friday.